Your browser doesn't support javascript.
loading
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
Osborne, Michael T; Hulten, Edward A; Murthy, Venkatesh L; Skali, Hicham; Taqueti, Viviany R; Dorbala, Sharmila; DiCarli, Marcelo F; Blankstein, Ron.
Affiliation
  • Osborne MT; Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. mosborne@partners.org.
  • Hulten EA; Non-Invasive Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA. mosborne@partners.org.
  • Murthy VL; Cardiology Service, Division of Medicine, Walter Reed National Military Medical Center and Uniformed Services University of Health Sciences, Bethesda, MD, USA.
  • Skali H; Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Taqueti VR; Divisions of Nuclear Medicine and Cardiothoracic Imaging, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
  • Dorbala S; Non-Invasive Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.
  • DiCarli MF; Non-Invasive Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.
  • Blankstein R; Non-Invasive Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.
J Nucl Cardiol ; 24(1): 86-99, 2017 02.
Article in En | MEDLINE | ID: mdl-27277502
ABSTRACT
Although the number of clinical applications for fluorine-18 fluorodeoxyglucose (18F-FDG) cardiac positron emission tomography (PET) has continued to grow, there remains a lack of consensus regarding the ideal method of suppressing normal myocardial glucose utilization for image optimization. This review describes various patient preparation protocols that have been used as well as the success rates achieved in different studies. Collectively, the available literature supports using a high-fat, no-carbohydrate diet for at least two meals with a fast of 4-12 hours prior to 18F-FDG PET imaging and suggests that isolated fasting for less than 12 hours and supplementation with food or drink just prior to imaging should be avoided. Each institution should adopt a protocol and continuously monitor its effectiveness with a goal to achieve adequate myocardial suppression in greater than 80% of patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Image Enhancement / Fasting / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Diet, Carbohydrate-Restricted / Cardiac Imaging Techniques / Myocarditis Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Nucl Cardiol Journal subject: CARDIOLOGIA Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Image Enhancement / Fasting / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Diet, Carbohydrate-Restricted / Cardiac Imaging Techniques / Myocarditis Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Nucl Cardiol Journal subject: CARDIOLOGIA Year: 2017 Document type: Article Affiliation country: